Top Stories

  • heartware

Heartware Blows a Gasket

By Joseph Mullings

The Heartware / Valtech deal has indicated to the market that the structural heart and in particular the mitral space has blown a gasket. It is great to see the M&A action in the space return to companies that are pre-revenue and pre-approval.

I am however sitting here scratching my head as to how in the heck does Heartware plan on making this work?

Valtech has a very nice product platform. We […]

  • China article

China is a Bad Bet

By Joseph Mullings

I started thinking about this over the past few weeks as my clients have been complaining about their projects they have going on in China. When transferring technologies or joint ventures in different technologies within the Med-Tech space, it seems, time after time, that there is a purposeful disconnect between the Chinese and the medical device companies that are either partnering or transferring technology to China.

Yesterday, I read in the New York Times […]

  • Tel Aviv Presentation

Clinical Leadership in Start Ups

By: Joe Mullings

I just returned from Tel Aviv, Israel after attending the ICI Conference. The conference was outstanding. I had the opportunity to present on a Sunday session that was specifically designed to be a sort of “boot camp” for entrepreneurs and start-up types. The title of my presentation was “How to Recruit the Best Athlete for Emerging Technology Companies”. The range of subjects from other presenters included financing, technology development, management of IP, etc.

After […]

International News

  • international II

Cardiac Dimensions® Initiates European Commercialization of CARILLON® Mitral Contour System®

Commercial Rollout includes PRIME Study, Collecting Data on up to 300 European Patients

KIRKLAND, Wash., Sept. 28, 2012 — /PRNewswire/ –Cardiac Dimensions®,Inc. today announced that it has initiated its commercial efforts in Europe, treating the first patients with its CARILLON® Mitral Contour System® under its Conformite […]

  • cash5

$265 million for Israeli-founded medical device company

An admirable exit for the Israeli-founded medical device company, Rhythmia Medical, as it gets picked up by Boston Scientific – a worldwide developer, manufacturer and marketer of medical devices- for $265 million.

The agreement (signed today) calls for an upfront payment of $90 million payable upon […]

  • tax

Implant scandal sparks revamp of EU medical device rules

*Rules to tighten product approvals, safety checks
* Changes follow French breast implant safety scandal
* Plans must be approved by EU governments, lawmakers

BRUSSELS, Sept 26 (Reuters) – The European Union has proposed tougher rules on assessing the safety and monitoring the use of medical devices and […]

  • surefire infusion system

European regulators approve Surefire Infusion System for chemo – and radioembolization procedures

European regulators have approved Surefire Medical’s Surefire Infusion System, a next generation device for chemo- and radioembolization procedures. The Colorado-based medical device company today announced that it is launching this product in the European market immediately.

“Surefire Medical developed this ground-breaking technology to provide interventional radiologists […]